Skip to content

With pressure to get products to market and meet corporate targets, it’s understandable that the returns and destruction elements of clinical trials are often something of an afterthought.

At Sharp, we proactively encourage our clients to plan ahead and create an outline plan for how returns, reconciliation and destruction will be managed during the set-up phase of the project. It’s the best way to make sure the process is handled as efficiently and cost-effectively as possible.

Our experts can help you plan ahead, so when your trial comes to an end you can focus on moving forward, knowing it’s all is taken care of. If you’re there already and need some extra support now, we also have well-established procedures that can be rolled out to any study at short notice.

Our services include:

  • Customer and project-specific returns and reconciliation protocols
  • Ample, dedicated returns storage
  • Regulatory compliance and documentation support
  • Reconciliation services
  • Hazardous and non-hazardous destruction
  • Updated and complete documentation on destruction
  • Issuing of certificates of destruction

Related Resources

If you’re attending #INTERPHEX, don’t miss the keynote session ‘Serialization on a Global Scale’ on 20 Oct.

Lauren Catalano joins a panel of global supply chain experts to discuss the US Drug Supply Chain Security Act (DSCSA).

Sign-up here: https://lnkd.in/e5E9WrxB

@INTERPHEX

Are you still managing your drug supply manually? Find out how you can save time with #Clinventory - our self-service, automated Inventory Management System.

Reach out to arrange a short demo and discover the power of Clinventory: https://lnkd.in/eKxDNDdH

The role of the EU Qualified person

Dr Ria Rhemrev from @Sharp_Services will take Manufacturing Chemist Live delegates through the role and its impacts on the end delivery in the supply chain.

Book now: https://bit.ly/3y2qQeZ

#ManChemLive